Search by Drug Name or NDC
NDC 68462-0879-05 Bisoprolol Fumarate and Hydrochlorothiazide 5; 6.25 mg/1; mg/1 Details
Bisoprolol Fumarate and Hydrochlorothiazide 5; 6.25 mg/1; mg/1
Bisoprolol Fumarate and Hydrochlorothiazide is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GLENMARK PHARMACEUTICALS INC., USA. The primary component is BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE.
MedlinePlus Drug Summary
Bisoprolol is used alone or in combination with other medications to treat high blood pressure. Bisoprolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve and decrease blood pressure. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 68462-0879-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Bisoprolol
Hydrochlorothiazide is used alone or in combination with other medications to treat high blood pressure. Hydrochlorothiazide is used to treat edema (fluid retention; excess fluid held in body tissues) caused by various medical problems, including heart, kidney, and liver disease and to treat edema caused by using certain medications including estrogen and corticosteroids. Hydrochlorothiazide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 68462-0879-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Hydrochlorothiazide
Product Information
| NDC | 68462-0879 |
|---|---|
| Product ID | 68462-879_75c16277-3d61-4c27-a853-485aa7669c0e |
| Associated GPIs | 36992002130320 |
| GCN Sequence Number | 021140 |
| GCN Sequence Number Description | bisoprolol/hydrochlorothiazide TABLET 5-6.25MG ORAL |
| HIC3 | J7H |
| HIC3 Description | BETA-BLOCKERS AND THIAZIDE,THIAZIDE-LIKE DIURETICS |
| GCN | 45062 |
| HICL Sequence Number | 008715 |
| HICL Sequence Number Description | BISOPROLOL FUMARATE/HYDROCHLOROTHIAZIDE |
| Brand/Generic | Generic |
| Proprietary Name | Bisoprolol Fumarate and Hydrochlorothiazide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bisoprolol Fumarate and Hydrochlorothiazide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 5; 6.25 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
| Labeler Name | GLENMARK PHARMACEUTICALS INC., USA |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215995 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 68462-0879-05 (68462087905)
| NDC Package Code | 68462-879-05 |
|---|---|
| Billing NDC | 68462087905 |
| Package | 500 TABLET, FILM COATED in 1 BOTTLE (68462-879-05) |
| Marketing Start Date | 2022-01-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.23386 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |